Lanlan Lou

697 total citations
23 papers, 577 citations indexed

About

Lanlan Lou is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Lanlan Lou has authored 23 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Pharmacology. Recurrent topics in Lanlan Lou's work include Metal-Organic Frameworks: Synthesis and Applications (2 papers), Endoplasmic Reticulum Stress and Disease (2 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). Lanlan Lou is often cited by papers focused on Metal-Organic Frameworks: Synthesis and Applications (2 papers), Endoplasmic Reticulum Stress and Disease (2 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). Lanlan Lou collaborates with scholars based in China, United States and Australia. Lanlan Lou's co-authors include Sheng Yin, Gui‐Hua Tang, Jian‐Yong Zhu, Junsheng Zhang, Xianzhang Bu, Jun Yan, Ling Huang, Xingshu Li, Yanqing Pang and Baijiao An and has published in prestigious journals such as ACS Nano, Hepatology and Journal of Medicinal Chemistry.

In The Last Decade

Lanlan Lou

21 papers receiving 570 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lanlan Lou China 13 229 193 113 88 65 23 577
M.J. Alcaraz Spain 12 180 0.8× 187 1.0× 124 1.1× 50 0.6× 29 0.4× 17 573
Marie-Hélène Teiten Luxembourg 14 426 1.9× 116 0.6× 129 1.1× 54 0.6× 73 1.1× 15 859
Taha F. S. Ali Egypt 19 286 1.2× 391 2.0× 77 0.7× 59 0.7× 36 0.6× 57 859
Ragini G. Bodade India 13 264 1.2× 530 2.7× 141 1.2× 42 0.5× 28 0.4× 26 875
Surya Kant Tripathi India 15 374 1.6× 144 0.7× 45 0.4× 137 1.6× 75 1.2× 34 784
Hassan Seradj Iran 17 259 1.1× 366 1.9× 46 0.4× 73 0.8× 80 1.2× 41 701
Ethiraj Kannatt Radhakrishnan India 14 155 0.7× 281 1.5× 143 1.3× 31 0.4× 66 1.0× 33 579
Mohammed Al‐Ghorbani Saudi Arabia 18 207 0.9× 492 2.5× 83 0.7× 55 0.6× 43 0.7× 60 780
Jo‐Anne de la Mare South Africa 15 255 1.1× 197 1.0× 37 0.3× 62 0.7× 36 0.6× 32 577
Mubashir J. Mintoo India 17 354 1.5× 173 0.9× 64 0.6× 24 0.3× 30 0.5× 25 698

Countries citing papers authored by Lanlan Lou

Since Specialization
Citations

This map shows the geographic impact of Lanlan Lou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanlan Lou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanlan Lou more than expected).

Fields of papers citing papers by Lanlan Lou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lanlan Lou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanlan Lou. The network helps show where Lanlan Lou may publish in the future.

Co-authorship network of co-authors of Lanlan Lou

This figure shows the co-authorship network connecting the top 25 collaborators of Lanlan Lou. A scholar is included among the top collaborators of Lanlan Lou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lanlan Lou. Lanlan Lou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yang, Weiping, Hongli Suo, Peipei Ma, et al.. (2025). Photocatalytic Reduction of Levulinic Acid to γ-Valerolactone on Non-noble Metal Bi2S3 Catalysts under Mild Reaction Conditions. ACS Sustainable Chemistry & Engineering. 13(13). 5057–5067.
3.
Yang, Bin, Mandy M. Chan, Gyu Seong Heo, et al.. (2024). Molecular imaging of macrophage composition and dynamics in MASLD. JHEP Reports. 6(12). 101220–101220. 2 indexed citations
5.
Heo, Gyu Seong, Lanlan Lou, Deborah Sultan, & Yongjian Liu. (2021). The Latest Advances in Imaging Crosstalk Between the Immune System and Fibrosis in Cardiovascular Disease. Journal of Nuclear Medicine. 62(10). 1341–1346. 2 indexed citations
6.
Zhang, Xiaohui, Lisa Detering, Hannah Luehmann, et al.. (2021). CC Chemokine Receptor 2-Targeting Copper Nanoparticles for Positron Emission Tomography-Guided Delivery of Gemcitabine for Pancreatic Ductal Adenocarcinoma. ACS Nano. 15(1). 1186–1198. 51 indexed citations
7.
Lou, Lanlan, Lin Chen, Wei Li, et al.. (2019). Germacrane Sesquiterpenoids as a New Type of Anticardiac Fibrosis Agent Targeting Transforming Growth Factor β Type I Receptor. Journal of Medicinal Chemistry. 62(17). 7961–7975. 7 indexed citations
9.
Yue, Xin, Yinglin Zuo, Jiaming Luo, et al.. (2017). Identification of 4-arylidene curcumin analogues as novel proteasome inhibitors for potential anticancer agents targeting 19S regulatory particle associated deubiquitinase. Biochemical Pharmacology. 137. 29–50. 15 indexed citations
10.
Feng, Guoshuai, Cuige Zhu, Zhuo-ming Li, et al.. (2017). Synthesis of the novel PARP-1 inhibitor AG-690/11026014 and its protective effects on angiotensin II-induced mouse cardiac remodeling. Acta Pharmacologica Sinica. 38(5). 638–650. 19 indexed citations
11.
Guo, Yan‐Qiong, Gui‐Hua Tang, Lanlan Lou, et al.. (2017). Prenylated flavonoids as potent phosphodiesterase-4 inhibitors from Morus alba : Isolation, modification, and structure-activity relationship study. European Journal of Medicinal Chemistry. 144. 758–766. 47 indexed citations
12.
Pang, Yanqing, Baijiao An, Lanlan Lou, et al.. (2017). Design, Synthesis, and Biological Evaluation of Novel Selenium-Containing Isocombretastatins and Phenstatins as Antitumor Agents. Journal of Medicinal Chemistry. 60(17). 7300–7314. 139 indexed citations
13.
Li, Wei, Lanlan Lou, Yunyun Chen, et al.. (2017). Biscembranoids and Cembranoids from the Soft Coral Sarcophyton elegans. Marine Drugs. 15(4). 85–85. 17 indexed citations
14.
Li, Wei, Lanlan Lou, Jian‐Yong Zhu, et al.. (2016). New lanostane-type triterpenoids from the fruiting body of Ganoderma hainanense. Fitoterapia. 115. 24–30. 20 indexed citations
15.
Cheng, Zhongbin, Lanlan Lou, Dong Liu, et al.. (2016). Versiquinazolines A–K, Fumiquinazoline-Type Alkaloids from the Gorgonian-Derived Fungus Aspergillus versicolor LZD-14-1. Journal of Natural Products. 79(11). 2941–2952. 49 indexed citations
16.
Lou, Lanlan, Jian‐Yong Zhu, Gui‐Hua Tang, et al.. (2015). Jatrocurcadiones A and B: two novel diterpenoids with an unusual 10,11-seco-premyrsinane skeleton from Jatropha curcas. RSC Advances. 5(77). 62921–62925. 18 indexed citations
17.
Zhu, Jian‐Yong, Lanlan Lou, Yan‐Qiong Guo, et al.. (2015). Natural thioredoxin reductase inhibitors from Jatropha integerrima. RSC Advances. 5(58). 47235–47243. 31 indexed citations
18.
Zhu, Jian‐Yong, Lanlan Lou, Yan‐Qiong Guo, et al.. (2015). ChemInform Abstract: Natural Thioredoxin Reductase Inhibitors from Jatropha integerrima.. ChemInform. 46(40). 1 indexed citations
19.
Yu, Kai, Zhongwei Gu, Rong Ji, et al.. (2007). Effect of pore size on the performance of mesoporous material supported chiral Mn(III) salen complex for the epoxidation of unfunctionalized olefins. Journal of Catalysis. 252(2). 312–320. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026